Published online before print
December 5, 2007, 10.1183/09031936.00064807
Eur Respir J 2008; 31:707-713
Copyright ©ERS Journals Ltd 2008
Gastro-oesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection
K. Blondeau1,
V. Mertens1,
B. A. Vanaudenaerde2,
G. M. Verleden2,
D. E. Van Raemdonck2,
D. Sifrim1 and
L. J. Dupont2
1 Centre for Gastroenterological Research, and 2 Lung Transplant Unit, University Hospital Gasthuisberg, Katholieke Universiteit, Leuven, Belgium.
CORRESPONDENCE: L. J. Dupont, Division of Respiratory Medicine, University Hospital Gasthuisberg, 49 Herestraat, B-3000 Leuven, Belgium. Fax: 32 16346803. E-mail: lieven.dupont{at}uz.kuleuven.be
Keywords: Bronchiolitis obliterans syndrome, gastro-oesophageal reflux, transplantation
Received: May 30, 2007
Accepted November 22, 2007
Acid gastro-oesophageal reflux (GOR) and gastric aspiration have been labelled as risk factors for chronic rejection bronchiolitis obliterans syndrome (BOS) after lung transplantation (LTx). The present study aimed to further characterise GOR (both acid and nonacid) and the degree of gastric aspiration in LTx recipients both with and without BOS.
Impedance-pH recordings were used for GOR detection. Pepsin and bile acid levels were measured in bronchoalveolar lavage fluid (BALF).
A total of 48% of patients had increased GOR, of which 27% had exclusively increased nonacid reflux. Cystic fibrosis patients had the highest prevalence of GOR. Pepsin was found in BALF of all patients and bile acids in BALF of 50% of the patients. Patients with BOS had neither increased GOR nor elevated pepsin in BALF. However, 70% of the patients with BOS had bile in BALF compared with 31% of stable patients. Proton pump inhibitor (PPI) treatment reduced acid reflux but did not affect nonacid reflux. Moreover, pepsin and bile levels in BALF were not reduced by PPI.
One-half of the lung transplant patients had increased reflux, and nonacid reflux was common. Gastric aspiration occurred in most lung transplant patients. Pepsin was a more general marker and bile acids a more specific marker that might be associated with bronchiolitis obliterans syndrome. Proton pump inhibitor treatment did not prevent nonacid reflux and gastric aspiration.
This article has been cited by other articles:

|
 |

|
 |
 
E. Savarino, M. Bazzica, P. Zentilin, D. Pohl, A. Parodi, G. Cittadini, S. Negrini, F. Indiveri, R. Tutuian, V. Savarino, et al.
Gastroesophageal Reflux and Pulmonary Fibrosis in Scleroderma: A Study Using pH-Impedance Monitoring
Am. J. Respir. Crit. Care Med.,
March 1, 2009;
179(5):
408 - 413.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kopanakis, C. Golias, M. Patentalakis, C. Mermigkis, A. Charalabopoulos, D. Peschos, A. Batistatou, and K. Charalabopoulos
Bilateral pulmonary nodules in an adult patient with bronchiolitis obliterans-organising pneumonia
BMJ Case Reports,
February 27, 2009;
2009(feb26_1):
bcr0820080809 - bcr0820080809.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. A. Belperio, S. S. Weigt, M. C. Fishbein, and J. P. Lynch III
Chronic Lung Allograft Rejection: Mechanisms and Therapy
Proceedings of the ATS,
January 15, 2009;
6(1):
108 - 121.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Levine
Lung Transplantation
ACCP Pulmonary Med Brd Rev,
January 1, 2009;
25(0):
563 - 584.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Lynch III
Idiopathic Pulmonary Fibrosis, Nonspecific Interstitial Pneumonia/Fibrosis, and Sarcoidosis
ACCP Pulmonary Med Brd Rev,
January 1, 2009;
25(0):
635 - 686.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. M. Vanaudenaerde, I. Meyts, R. Vos, N. Geudens, W. De Wever, E. K. Verbeken, D. E. Van Raemdonck, L. J. Dupont, and G. M. Verleden
A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy
Eur. Respir. J.,
October 1, 2008;
32(4):
832 - 842.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2008 by the European Respiratory Society.
|